Baxalta in talks to buy U.S. hematology-oncology specialist ? Bloomberg
 

Baxalta in talks to buy U.S. hematology-oncology specialist ? Bloomberg
Aug 28 (Reuters) - Drugmaker Baxalta Inc is working with bankers to buy a U.S.-based hematology and oncology specialist valued at about $2 billion, Bloomberg reported, citing people familiar with the...http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...Xk:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...Xk:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/ECW_AHVEyN8